These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 10835624

  • 21. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides.
    Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, Takehara K, Saijoh K.
    J Invest Dermatol; 2002 Mar; 118(3):436-43. PubMed ID: 11874482
    [Abstract] [Full Text] [Related]

  • 22. SPINK5 gene mutation and decreased LEKTI activity in three Chinese patients with Netherton's syndrome.
    Zhao Y, Ma ZH, Yang Y, Yang SX, Wu LS, Ding BL, Lin ZM, Wang AP, Bu DF, Tu P.
    Clin Exp Dermatol; 2007 Sep; 32(5):564-7. PubMed ID: 17608759
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.
    Egelrud T, Brattsand M, Kreutzmann P, Walden M, Vitzithum K, Marx UC, Forssmann WG, Mägert HJ.
    Br J Dermatol; 2005 Dec; 153(6):1200-3. PubMed ID: 16307658
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
    Komatsu N, Saijoh K, Jayakumar A, Clayman GL, Tohyama M, Suga Y, Mizuno Y, Tsukamoto K, Taniuchi K, Takehara K, Diamandis EP.
    J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
    [Abstract] [Full Text] [Related]

  • 27. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
    Roedl D, Oji V, Buters JT, Behrendt H, Braun-Falco M.
    J Dermatol Sci; 2011 Mar; 61(3):194-8. PubMed ID: 21251800
    [Abstract] [Full Text] [Related]

  • 28. LEKTI domain 15 is a functional Kazal-type proteinase inhibitor.
    Vitzithum K, Lauber T, Kreutzmann P, Schulz A, Sommerhoff CP, Rösch P, Marx UC.
    Protein Expr Purif; 2008 Jan; 57(1):45-56. PubMed ID: 17936012
    [Abstract] [Full Text] [Related]

  • 29. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.
    Komatsu N, Saijoh K, Otsuki N, Kishi T, Micheal IP, Obiezu CV, Borgono CA, Takehara K, Jayakumar A, Wu HK, Clayman GL, Diamandis EP.
    Clin Chim Acta; 2007 Feb; 377(1-2):228-36. PubMed ID: 17140555
    [Abstract] [Full Text] [Related]

  • 30. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.
    Bitoun E, Micheloni A, Lamant L, Bonnart C, Tartaglia-Polcini A, Cobbold C, Al Saati T, Mariotti F, Mazereeuw-Hautier J, Boralevi F, Hohl D, Harper J, Bodemer C, D'Alessio M, Hovnanian A.
    Hum Mol Genet; 2003 Oct 01; 12(19):2417-30. PubMed ID: 12915442
    [Abstract] [Full Text] [Related]

  • 31. Upregulation of interleukin-33 in the epidermis of two Japanese patients with Netherton syndrome.
    Konishi T, Tsuda T, Sakaguchi Y, Imai Y, Ito T, Hirota S, Yamanishi K.
    J Dermatol; 2014 Mar 01; 41(3):258-61. PubMed ID: 24506793
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
    Mitsudo K, Jayakumar A, Henderson Y, Frederick MJ, Kang Y, Wang M, El-Naggar AK, Clayman GL.
    Biochemistry; 2003 Apr 08; 42(13):3874-81. PubMed ID: 12667078
    [Abstract] [Full Text] [Related]

  • 33. Intrafamily and Interfamilial Phenotype Variation and Immature Immunity in Patients With Netherton Syndrome and Finnish SPINK5 Founder Mutation.
    Hannula-Jouppi K, Laasanen SL, Ilander M, Furio L, Tuomiranta M, Marttila R, Jeskanen L, Häyry V, Kanerva M, Kivirikko S, Tuomi ML, Heikkilä H, Mustjoki S, Hovnanian A, Ranki A.
    JAMA Dermatol; 2016 Apr 08; 152(4):435-42. PubMed ID: 26865388
    [Abstract] [Full Text] [Related]

  • 34. Deleterious mutations in SPINK5 in a patient with congenital ichthyosiform erythroderma: molecular testing as a helpful diagnostic tool for Netherton syndrome.
    Sprecher E, Tesfaye-Kedjela A, Ratajczak P, Bergman R, Richard G.
    Clin Exp Dermatol; 2004 Sep 08; 29(5):513-7. PubMed ID: 15347338
    [Abstract] [Full Text] [Related]

  • 35. The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.
    Mägert HJ, Kreutzmann P, Drögemüller K, Ständker L, Adermann K, Walden M, John H, Korting HC, Forssmann WG.
    Eur J Med Res; 2002 Feb 21; 7(2):49-56. PubMed ID: 11891144
    [Abstract] [Full Text] [Related]

  • 36. Characterization and expression analysis of the Spink5 gene, the mouse ortholog of the defective gene in Netherton syndrome.
    Galliano MF, Roccasecca RM, Descargues P, Micheloni A, Levy E, Zambruno G, D'Alessio M, Hovnanian A.
    Genomics; 2005 Apr 21; 85(4):483-92. PubMed ID: 15780751
    [Abstract] [Full Text] [Related]

  • 37. Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome.
    Hewett DR, Simons AL, Mangan NE, Jolin HE, Green SM, Fallon PG, McKenzie AN.
    Hum Mol Genet; 2005 Jan 15; 14(2):335-46. PubMed ID: 15590704
    [Abstract] [Full Text] [Related]

  • 38. Genetic analysis of a severe case of Netherton syndrome and application for prenatal testing.
    Müller FB, Hausser I, Berg D, Casper C, Maiwald R, Jung A, Jung H, Korge BP.
    Br J Dermatol; 2002 Mar 15; 146(3):495-9. PubMed ID: 11952552
    [Abstract] [Full Text] [Related]

  • 39. New homozygous SPINK5 mutation, p.Gln333X, in a Turkish pedigree with Netherton syndrome.
    Fong K, Akdeniz S, Isi H, Taskesen M, McGrath JA, Lai-Cheong JE.
    Clin Exp Dermatol; 2011 Jun 15; 36(4):412-5. PubMed ID: 21564178
    [Abstract] [Full Text] [Related]

  • 40. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
    Wang S, Olt S, Schoefmann N, Stuetz A, Winiski A, Wolff-Winiski B.
    Exp Dermatol; 2014 Jul 15; 23(7):524-6. PubMed ID: 24848304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.